A new approach to treatment-resistant depression
We recognize that there is currently a need for access to fast-acting and effective therapeutic interventions for patients with Treatment-Resistant Depression. An effective treatment requires an approach based on a complete assessment and a comprehensive therapeutic plan that includes pharmacological and non-pharmacological components, seeking an intervention based on a biopsychosocial model.
Over the last two decades, research into psychedelic drugs has been producing evidence that points to their effectiveness and safety in treating people diagnosed with Depression.
Meet our clinical team
SOMA's core team is made up of two Psychiatry doctors with specialized training and clinical experience in the use of psychedelics in psychiatric disorders. This team works together with other mental health professionals from Casa de Saúde de Santa Catarina, so that all necessary care is provided during treatment.
What does the treatment consist of?
Understand, step by step, what treatment with a psychedelic drug involves, which has been gathering increasing evidence of efficacy and safety in the treatment of Depression.
We clarify your doubts
Consult our Frequently Asked Questions section to clarify all your doubts about our approach: who it is suitable for, how long the treatment lasts and the main precautions you should take.
Treatment only begins after an Assessment Consultation, which serves the purpose of confirming that the inclusion criteria for the treatment are present and that there are no criteria that could contraindicate it.